MG 126 (-)-ß-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, [2-13C, 1,3-15N2 99 atom % 13C, 98 atom % 15N2]-
Click here for Typical Certificate of Analysis
|
| (FTC, [2-13C, 1,3-15N2]-),
(Emtricitabine, [2-13C, 1,3-15N2]-) |
| MORpure™ HPLC
purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram |
| Lyophilized solid |
1 mg $615 |
| Screw cap v-vial - shipped on dry ice |
M.W. 250.2
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 2031 (-)-ß-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, [2-14C]-
|
| (FTC, [2-14C]-),
(Emtricitabine, [2-14C]-) |
| MORpure™ HPLC
purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram |
| Ethanol:water (1:1)
solution under argon, 100 µCi/ml |
10 µCi (370
kBq) $1240 |
| > 45 mCi(1.665 GBq)/mmol |
50 µCi (1.85
MBq) $3970 |
| NextGen V-Vial - shipped on dry ice |
M.W. 247.25
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1605 (-)-ß-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, [6-3H]-
|
| (FTC, [6-3H]-),
(Emtricitabine, [6-3H]-) |
| MORpure™ HPLC
purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
| Ethanol:water (1:1) solution
under argon, 1 mCi/ml |
|
| ≥ 2 Ci(74 GBq)/mmol |
50 μCi (1.85
MBq) $1160 |
| NextGen V-Vial - shipped on dry ice |
M.W. 247.25
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
M 1911 (-)-ß-L-2',3'-Dideoxy-5-fluoro-3'-thiacytidine-5'-diphosphate, triammonium salt (Non-labeled)
|
| (FTC-DP, triammonium salt), (Emtricitabine-DP,
triammonium salt) |
| Delivered ≥ 93%
pure with dated HPLC UV chromatogram |
| Solid |
2
µmol $3495 |
| Screw cap v-vial - shipped on dry ice |
| M.W. 458.3 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
M 1884 Emtricitabine 5'-monophosphate, diammonium salt
Click here for Typical Certificate of Analysis
|
| (FTC-MP, diammonium salt), (Emtricitabine-MP,
diammonium salt) |
| Delivered ≥ 93%
pure with dated HPLC UV chromatogram |
| Solid |
Please
Inquire for Pricing |
| Screw cap v-vial - shipped on dry ice |
| M.W. 361.29 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
M 1596 (-)-ß-L-2',3'-Dideoxy-3'-thia-5-fluorocytidine-5'-triphosphate, tetraammonium salt (Non-labeled)
|
| Click
here for Typical
Certificate of Analysis |
| (FTC-TP,
tetraammonium salt), (Emtricitabine-TP,
tetraammonium salt) |
| Delivered ≥ 93%
pure with dated HPLC UV chromatogram |
| Solid |
Please
Inquire for Pricing |
| Screw cap v-vial - shipped on dry ice |
M.W. 553.31
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
